Literature DB >> 435956

Allopurinol hypersensitivity.

M W McKendrick, A M Geddes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 435956      PMCID： PMC1598652          DOI： 10.1136/bmj.1.6169.988

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Aplastic agranulocytosis after allopurinol therapy.

Authors:  M S Greenberg; S S Zambrano
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

2.  Toxic epidermal necrolysis, azotemia, and death after allopurinol therapy.

Authors:  G L Kantor
Journal:  JAMA       Date:  1970-04-20       Impact factor: 56.272

3.  Urinary xanthine stones--a rare complications of allopurinol therapy.

Authors:  M L Greene; W Y Fujimoto; J E Seegmiller
Journal:  N Engl J Med       Date:  1969-02-20       Impact factor: 91.245

4.  Liver granulomas and allopurinol.

Authors:  A Medline; L B Cohen; B A Tobe; E M Sellers
Journal:  Br Med J       Date:  1978-05-20

5.  Allpurinol hypersensitivity syndrome: effects and treatment.

Authors:  S W Lindsey; E F Evans
Journal:  Va Med       Date:  1978-04
  5 in total
  4 in total

Review 1.  Tumor lysis syndrome: new challenges and recent advances.

Authors:  F Perry Wilson; Jeffrey S Berns
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

2.  Acute adverse reactions attributed to allopurinol in hospitalised patients.

Authors:  G T McInnes; D H Lawson; H Jick
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

3.  Kinetics of allopurinol after single intravenous and oral doses. Noninteraction with benzbromarone and hydrochlorothiazide.

Authors:  B Breithaupt; M Tittel
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 4.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.